Literature DB >> 2650522

Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk.

G Assmann1, H Schulte.   

Abstract

Age is an important factor in predicting risk of myocardial infarction (MI). Age is currently treated as an independent variable in assessing risk, but it is also related to other major risk factors including hyperlipidemia, hypertension and diabetes, all of which increase in prevalence with age. Current evidence indicates that a combination of 2 or more of the major risk factors predisposes a person to a high risk of MI. In the experience of the Prospective Cardiovascular Munster study, patients with diabetes alone have twice the risk of MI, but those with diabetes and hyperlipidemia have about a 15-fold increased risk. Similarly, patients with hypertension alone have twice the risk of MI, but those with hypertension combined with hyperlipidemia have approximately a 15-fold increased risk.

Entities:  

Mesh:

Year:  1989        PMID: 2650522     DOI: 10.1016/0002-9149(89)90113-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men.

Authors:  J H Stengård; J Pekkanen; C Ehnholm; A Nissinen; C F Sing
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  M R Joffres; P Hamet; S W Rabkin; D Gelskey; K Hogan; G Fodor
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

3.  Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).

Authors:  R Bergemann; A Brandt; W Siegrist
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

4.  Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.

Authors:  S Perreault; M Dorais; L Coupal; G Paradis; M R Joffres; S A Grover
Journal:  CMAJ       Date:  1999-05-18       Impact factor: 8.262

5.  Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction.

Authors:  Marius Carstensen; Claus Thomsen; Ole Gotzsche; Jens Juul Holst; Jürgen Schrezenmeir; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2005-02-10

Review 6.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

7.  Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.

Authors:  D J Paulson; A L Shug; J Zhao
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

8.  Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-23       Impact factor: 3.738

9.  Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry.

Authors:  Thomas Scheffold; Silke Kullmann; Andreas Huge; Priska Binner; Hermann R Ochs; Wolfgang Schöls; Joachim Thale; Wolfgang Motz; Franz Josef Hegge; Christoph Stellbrink; Thomas Dorsel; Hartmut Gülker; Hubertus Heuer; Wilfried Dinh; Monika Stoll; Georg Haltern
Journal:  BMC Cardiovasc Disord       Date:  2011-03-07       Impact factor: 2.298

10.  Prevalence and control of hypertension and albuminuria in South Korea: focus on obesity and abdominal obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Su-Jung Yoon; Do-Hoon Kim; Ga-Eun Nam; Yeo-Joon Yoon; Kyung-Do Han; Dong-Wook Jung; Sang-Woon Park; Young-Eun Kim; Sung-Ho Lee; Sang-Su Lee; Yang-Hyun Kim
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.